Bank Of America Corp Protalix Bio Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.43 Trillion
Q3 2025

A detailed history of Bank Of America Corp transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 20,119 shares of PLX stock, worth $37,421. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,119

Previous 21,892 8.1%

Holding current value

$37,421

Previous $32,000 37.5%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$1.38 - $2.23 $2,446 - $3,953	-1,773 Reduced 8.1%	20,119 $44,000
Q2 2025 Aug 14, 2025	BUY	$1.35 - $3.07 $29,546 - $67,190	21,886 Added 364766.66%	21,892 $32,000
Q1 2025 May 15, 2025	SELL	$1.88 - $2.69 $63,371 - $90,674	-33,708 Reduced 99.98%	6 $0
Q4 2024 Feb 14, 2025	SELL	$0.99 - $1.92 $11,167 - $21,657	-11,280 Reduced 25.07%	33,714 $64,000
Q3 2024 Nov 14, 2024	SELL	$0.9 - $1.17 $59,553 - $77,418	-66,170 Reduced 59.52%	44,994 $45,000

Q2 2024 Aug 14, 2024	SELL	$1.1 - $1.32 $3,735 - $4,482	-3,396 Reduced 2.96%	111,164 $130,000
Q1 2024 May 15, 2024	SELL	$1.22 - $1.82 $108,040 - $161,175	-88,558 Reduced 43.6%	114,560 $144,000
Q4 2023 Feb 14, 2024	BUY	$1.34 - $1.85 $177,354 - $244,854	132,354 Added 187.04%	203,118 $361,000
Q2 2023 Aug 14, 2023	BUY	$2.0 - $3.36 $141,450 - $237,636	70,725 Added 181346.16%	70,764 $141,000
Q1 2023 May 12, 2023	SELL	$1.37 - $2.16 $4,011 - $6,324	-2,928 Reduced 98.69%	39 $0
Q4 2022 Feb 10, 2023	SELL	$1.0 - $1.37 $60 - $82	-60 Reduced 1.98%	2,967 $4,000
Q3 2022 Nov 14, 2022	SELL	$1.03 - $1.24 $491 - $591	-477 Reduced 13.61%	3,027 $3,000
Q2 2022 Aug 12, 2022	SELL	$1.02 - $1.56 $1,681 - $2,572	-1,649 Reduced 32.0%	3,504 $3,000
Q1 2022 May 16, 2022	SELL	$0.81 - $1.17 $9,909 - $14,313	-12,234 Reduced 70.36%	5,153 $5,000
Q4 2021 Feb 08, 2022	BUY	$0.81 - $1.33 $6,882 - $11,301	8,497 Added 95.58%	17,387 $14,000
Q3 2021 Nov 15, 2021	BUY	$1.31 - $1.87 $3,952 - $5,641	3,017 Added 51.37%	8,890 $12,000
Q2 2021 Sep 13, 2021	BUY	$1.86 - $6.22 $10,923 - $36,530	5,873 New	5,873 $11,000

Others Institutions Holding PLX

# of Institutions

Shares Held

10.6M

Call Options Held

23.6K

Put Options Held

95.4K

View Full List

About Protalix BioTherapeutics, Inc.

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $92.5M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

More about PLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Protalix Bio Therapeutics, Inc. Transaction History